Raytheon awarded $71 million in Navy contracts for missile systems
Investing.com - Macquarie downgraded Yunnan Botanee Bio-Technology Group Co Ltd (SZ:300957) stock rating from Outperform to Underperform, while lowering its price target to RMB42.00 from RMB46.00.
The downgrade follows disappointing second-quarter performance, with Yunnan Botanee reporting a 16.7% year-over-year revenue decline in Q2 2025, worse than the 13.5% drop seen in the first quarter.
Macquarie noted the company’s dual-platform strategy, using TMall to retain existing customers while leveraging Douyin for new customer acquisition, has shown slow progress year-to-date, particularly in ramping up its Douyin presence.
While TMall remains Yunnan Botanee’s primary sales platform, its growth has lagged behind the performance on Douyin, according to the research firm’s assessment.
Macquarie acknowledged that Douyin still offers growth potential for the brand but expressed uncertainty about whether the company can accurately capture consumer demand and achieve rapid growth on this platform.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.